Molecular Endocrinology, Vol 10, 672-681, Copyright © 1996 by Endocrine Society

ARTICLES

DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression

M Falzon
Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston 77555, USA.

Expression of the gene encoding PTH-related peptide (PTHrP), a protein that plays a primary role in the development of humoral hypercalcemia of malignancy, is down-regulated at the transcriptional level by 1,25- dihydroxyvitamin D3 [1,25-(OH)2D3]. Deletions of the 5'-flanking region of the rat PTHrP gene, when fused to the chloramphenicol acetyl- transferase gene and transfected into ROS 17/2.8 (rat osteosarcoma) cells, showed that the 1,25-(OH)2D3 responsive region is located between -1.05 and -0.71 kb upstream of the transcription start site. Further mapping of this region revealed that a 123-bp fragment is able to confer 1,25-(OH)2D3 responsiveness to a heterologous (SV40) promoter. This region contains two potential vitamin D response elements (VDREs). One of these motifs resembles the negative VDRE (nVDRE) from the PTH gene, which is also down-regulated by vitamin D3. The other element resembles the canonical VDRE (two hexanucleotide motifs separated by three nucleotides), which has been characterized in a number of genes whose expression is modulated by vitamin D3. Electrophoretic mobility shift assays using nuclear extracts from ROS 17/2,8 cells and from vitamin D receptor. (VDR)-enriched COS 1 cells revealed that both elements interact with the VDR. This protein-DNA interaction is disrupted by an anti-VDR antibody. Therefore, modulation of PTHrP gene transcription by 1,25-(OH)2D3 is mediated by the VDR interacting with one or both of the identified motifs in the 5'- flanking sequence of the gene.

This article has been cited by other articles:

				M. M. Turunen, T. W. Dunlop, C. Carlberg, and S. Vaisanen Selective use of multiple vitamin D response elements underlies the 1 {alpha} ,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene Nucleic Acids Res., April 10, 2007; (2007) gkm179v1. [Abstract] [Full Text] [PDF]

				M.-s. Kim, R. Fujiki, A. Murayama, H. Kitagawa, K. Yamaoka, Y. Yamamoto, M. Mihara, K.-i. Takeyama, and S. Kato 1{alpha},25(OH)2D3-Induced Transrepression by Vitamin D Receptor through E-Box-Type Elements in the Human Parathyroid Hormone Gene Promoter Mol. Endocrinol., February 1, 2007; 21(2): 334 - 342. [Abstract] [Full Text] [PDF]

				S. Seoane and R. Perez-Fernandez The Vitamin D Receptor Represses Transcription of the Pituitary Transcription Factor Pit-1 Gene without Involvement of the Retinoid X Receptor Mol. Endocrinol., April 1, 2006; 20(4): 735 - 748. [Abstract] [Full Text] [PDF]

				S. Nagpal, S. Na, and R. Rathnachalam Noncalcemic Actions of Vitamin D Receptor Ligands Endocr. Rev., August 1, 2005; 26(5): 662 - 687. [Abstract] [Full Text] [PDF]

				K. Nakagawa, Y. Sasaki, S. Kato, N. Kubodera, and T. Okano 22-Oxa-1{alpha},25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer Carcinogenesis, June 1, 2005; 26(6): 1044 - 1054. [Abstract] [Full Text] [PDF]

				J.-C. Hsieh, J. M. Sisk, P. W. Jurutka, C. A. Haussler, S. A. Slater, M. R. Haussler, and C. C. Thompson Physical and Functional Interaction between the Vitamin D Receptor and Hairless Corepressor, Two Proteins Required for Hair Cycling J. Biol. Chem., October 3, 2003; 278(40): 38665 - 38674. [Abstract] [Full Text] [PDF]

				N. Ikeda, H. Uemura, H. Ishiguro, M. Hori, M. Hosaka, S. Kyo, K.-i. Miyamoto, E. Takeda, and Y. Kubota Combination Treatment with 1{alpha},25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Directly Inhibits Human Telomerase Reverse Transcriptase Transcription in Prostate Cancer Cells Mol. Cancer Ther., August 1, 2003; 2(8): 739 - 746. [Abstract] [Full Text] [PDF]

				S. Chen, C. H. R. M. Costa, K. Nakamura, R. C. J. Ribeiro, and D. G. Gardner Vitamin D-dependent Suppression of Human Atrial Natriuretic Peptide Gene Promoter Activity Requires Heterodimer Assembly J. Biol. Chem., April 16, 1999; 274(16): 11260 - 11266. [Abstract] [Full Text] [PDF]

				N. J. Koszewski, S. Ashok, and J. Russell Turning a Negative into a Positive: Vitamin D Receptor Interactions with the Avian Parathyroid Hormone Response Element Mol. Endocrinol., March 1, 1999; 13(3): 455 - 465. [Abstract] [Full Text]

				S. Jono, Y. Nishizawa, A. Shioi, and H. Morii 1,25-Dihydroxyvitamin D3 Increases In Vitro Vascular Calcification by Modulating Secretion of Endogenous Parathyroid Hormone–Related Peptide Circulation, September 29, 1998; 98(13): 1302 - 1306. [Abstract] [Full Text] [PDF]

				T. Nishishita, T. Okazaki, T. Ishikawa, T. Igarashi, K. Hata, E. Ogata, and T. Fujita A Negative Vitamin D Response DNA Element in the Human Parathyroid Hormone-related Peptide Gene Binds to Vitamin D Receptor Along with Ku Antigen to Mediate Negative Gene Regulation by Vitamin D J. Biol. Chem., May 1, 1998; 273(18): 10901 - 10907. [Abstract] [Full Text] [PDF]

				M. Falzon and J. Zong The Noncalcemic Vitamin D Analogs EB1089 and 22-Oxacalcitriol Suppress Serum-Induced Parathyroid Hormone-Related Peptide Gene Expression in a Lung Cancer Cell Line Endocrinology, March 1, 1998; 139(3): 1046 - 1053. [Abstract] [Full Text] [PDF]

				Y. Ezura, O. Tournay, A. Nifuji, and M. Noda Identification of a Novel Suppressive Vitamin D Response Sequence in the 5'-Flanking Region of the Murine Id1 Gene J. Biol. Chem., November 21, 1997; 272(47): 29865 - 29872. [Abstract] [Full Text] [PDF]